StockTipsArenaBeta

BUY Mankind Pharma Limited — Somil Mehta, Sharekhan

BUYMankind Pharma Limited

bySomil Mehta, SharekhanHorizon: 1–3 months6 Jul 2026via CNBC Awaaz.

Entry₹2,541.5Inferred
Target₹2,800
Total upside +10.17%
Stop lossNot given
CMP₹2,320Just now
Active-8.72%+20.69%upside left 4 wk left
Follow Somil Mehta for new calls(37% target hit, 43 closed calls)Get alertsWatch MANKIND for new buy/sell callsGet alertsSee 1 other Short-term call on MANKINDSee 26 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 1:19 pm IST
13 supporting8 neutral1 opposing
Supports the BUY call (13)

MACD above its signal line — bullish momentum

Technicals · macd·8 Sept · today

5 advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · adjacent horizon·2 Sept · 6d ago

Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets

NewsEt-Markets·28 Aug · 1w ago

(opens in new tab)

Mankind Pharma inks exclusive deal for two insulin analogues in India

NewsCnbc-Tv18·20 Aug · 3w ago

(opens in new tab)

Mankind Pharma has entered into an exclusive in-licensing agreement for Insulin Degludec and its combination for the Indian market. This strategic move aims to expand the company's product portfolio i

NSE · Press Release·20 Aug · 3w ago

(opens in new tab)
Neutral / worth noting (8)

Mankind Pharma Limited's Board approved the integration of its wholly owned subsidiary, Bharat Serums and Vaccines Limited, into the company via voluntary liquidation.

NSE · Outcome of Board Meeting·26 Aug · 2w ago

(opens in new tab)

Mankind Pharma completes security realignment and releases pledged shares worth 38.68% of Bharat Serums and Vaccines' equity

NewsGoogle News·17 Aug · 3w ago

(opens in new tab)

Mankind Pharma Releases BSVL Share Pledge, Realignment of NCD Security Complete

NewsGoogle News·17 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (1)

1 advisor has an active long-term SELL call on this stock

Advisor consensus · adjacent horizon·31 Jul · 1mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.